Cargando…
Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications
This article outlines evidence that advanced glycation end product (AGE) inhibitors and breakers act primarily as chelators, inhibiting metal-catalyzed oxidation reactions that catalyze AGE formation. We then present evidence that chelation is the most likely mechanism by which ACE inhibitors, angio...
Autores principales: | Nagai, Ryoji, Murray, David B., Metz, Thomas O., Baynes, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282805/ https://www.ncbi.nlm.nih.gov/pubmed/22354928 http://dx.doi.org/10.2337/db11-1120 |
Ejemplares similares
-
Controlled human malaria infection—Maker and breaker of dogma
por: Chavatte, Jean-Marc, et al.
Publicado: (2021) -
Nuage condensates: accelerators or circuit breakers for sRNA silencing pathways?
por: Ouyang, John Paul Tsu, et al.
Publicado: (2022) -
The Critical Role of Metabolic Pathways in Aging
por: Barzilai, Nir, et al.
Publicado: (2012) -
Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
por: Beitelshees, Amber L., et al.
Publicado: (2019) -
Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans?
por: Liu, Jiwen (Jim), et al.
Publicado: (2012)